{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05314738",
            "orgStudyIdInfo": {
                "id": "NXL-101-KCON"
            },
            "organization": {
                "fullName": "Glaukos Corporation",
                "class": "INDUSTRY"
            },
            "briefTitle": "Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus",
            "officialTitle": "A Dose Ranging, Multicenter, Sham-Controlled Study to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects With Keratoconus",
            "therapeuticArea": [
                "Other"
            ],
            "study": "safety-and-efficacy-of-corneal-cross-linking-in-subjects-with-keratoconus"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-03-08",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-08",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-03-29",
            "studyFirstSubmitQcDate": "2022-03-29",
            "studyFirstPostDateStruct": {
                "date": "2022-04-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-04",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-08",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Glaukos Corporation",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "Clinical Trial to Evaluate the Safety and Efficacy of Corneal Cross-linking in Subjects with Keratoconus.",
            "detailedDescription": "This is a a dose ranging, multi-center, sham-controlled study to evaluate the safety and efficacy of epithelium-on corneal collagen cross-linking. The study will evaluate safety and efficacy in subjects who have keratoconus."
        },
        "conditionsModule": {
            "conditions": [
                "Progressive Keratoconus"
            ],
            "keywords": [
                "Eye rubbing",
                "Collagen cross-linking",
                "Keratoconus",
                "Progressive Keratoconus"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1",
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "SINGLE",
                    "whoMasked": [
                        "PARTICIPANT"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 150,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 1 / Cohort 1",
                    "type": "EXPERIMENTAL",
                    "description": "Riboflavin Solution + Exposure to NXL system to achieve total energy level 3",
                    "interventionNames": [
                        "Combination Product: NXL Energy 3"
                    ]
                },
                {
                    "label": "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 3 / Cohort 2A",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Riboflavin Solution + Exposure to NXL system to achieve total energy level 1",
                    "interventionNames": [
                        "Combination Product: NXL Energy 1"
                    ]
                },
                {
                    "label": "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 4 / Cohort 2A",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Riboflavin Solution + Exposure to NXL system to achieve total energy level 2",
                    "interventionNames": [
                        "Combination Product: NXL Energy 2"
                    ]
                },
                {
                    "label": "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 5 / Cohort 2A",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Riboflavin Solution + Exposure to NXL system to achieve total energy level 3",
                    "interventionNames": [
                        "Combination Product: NXL Energy 3"
                    ]
                },
                {
                    "label": "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 3 / Cohort 2B",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Riboflavin Solution + Exposure to NXL system to achieve total energy level 1",
                    "interventionNames": [
                        "Combination Product: NXL Energy 1"
                    ]
                },
                {
                    "label": "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 4 / Cohort 2B",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Riboflavin Solution + Exposure to NXL system to achieve total energy level 2",
                    "interventionNames": [
                        "Combination Product: NXL Energy 2"
                    ]
                },
                {
                    "label": "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 5 / Cohort 2B",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Riboflavin Solution + Exposure to NXL system to achieve total energy level 3",
                    "interventionNames": [
                        "Combination Product: NXL Energy 3"
                    ]
                },
                {
                    "label": "Placebo Group 2 / Cohort 2B",
                    "type": "SHAM_COMPARATOR",
                    "description": "Sham Solution with no exposure to NXL System",
                    "interventionNames": [
                        "Combination Product: Sham Treatment"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "NXL Energy 1",
                    "description": "Riboflavin drops + NXL System to Total Energy Level 1",
                    "armGroupLabels": [
                        "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 3 / Cohort 2A",
                        "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 3 / Cohort 2B"
                    ]
                },
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "NXL Energy 2",
                    "description": "Riboflavin drops + NXL System to Total Energy Level 2",
                    "armGroupLabels": [
                        "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 4 / Cohort 2A",
                        "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 4 / Cohort 2B"
                    ]
                },
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "NXL Energy 3",
                    "description": "Riboflavin drops + NXL System to Total Energy Level 3",
                    "armGroupLabels": [
                        "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 1 / Cohort 1",
                        "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 5 / Cohort 2A",
                        "Riboflavin Ophthalmic Solution and UV-A Irradiation Group 5 / Cohort 2B"
                    ]
                },
                {
                    "type": "COMBINATION_PRODUCT",
                    "name": "Sham Treatment",
                    "description": "Sham Drops and No exposure to NXL system",
                    "armGroupLabels": [
                        "Placebo Group 2 / Cohort 2B"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Topography",
                    "description": "Change in Kmax topography value from baseline",
                    "timeFrame": "12 Months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Distance Uncorrected Visual Acuity (UCVA)",
                    "description": "Change in Distance UCVA",
                    "timeFrame": "12 Months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Provide written informed consent\n* Ability to hold gaze sufficiently stable for study testing\n* Willingness and ability to follow all instructions and comply with schedule for follow-up visits\n* Have a diagnosis of keratoconus\n\nExclusion Criteria:\n\n* Known allergy or sensitivity to the test articles or components\n* Any disease causing abnormal topography other than keratoconus\n* Prior or current ocular condition (other than keratoconus) in the study eye that may predispose the eye for future complications",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "55 Years",
            "stdAges": [
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Marco Armijo",
                    "role": "CONTACT",
                    "phone": "562-761-7965",
                    "email": "marmijo@glaukos.com"
                }
            ],
            "locations": [
                {
                    "facility": "Glaukos Investigative Site",
                    "status": "RECRUITING",
                    "city": "Dothan",
                    "state": "Alabama",
                    "zip": "36301",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 31.22323,
                        "lon": -85.39049
                    }
                },
                {
                    "facility": "Glaukos Investigative Site",
                    "status": "RECRUITING",
                    "city": "Teaneck",
                    "state": "New Jersey",
                    "zip": "07666",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.8976,
                        "lon": -74.01597
                    }
                },
                {
                    "facility": "Glaukos Investigative Site",
                    "status": "RECRUITING",
                    "city": "Westerville",
                    "state": "Ohio",
                    "zip": "43082",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 40.12617,
                        "lon": -82.92907
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000007640",
                    "term": "Keratoconus"
                }
            ],
            "ancestors": [
                {
                    "id": "D000003316",
                    "term": "Corneal Diseases"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M10666",
                    "name": "Keratoconus",
                    "asFound": "Keratoconus",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6539",
                    "name": "Corneal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T4202",
                    "name": "Oculocerebral Syndrome With Hypopigmentation",
                    "relevance": "LOW"
                },
                {
                    "id": "T3218",
                    "name": "Keratoconus",
                    "asFound": "Keratoconus",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M12814",
                    "name": "Ophthalmic Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M15085",
                    "name": "Riboflavin",
                    "relevance": "LOW"
                },
                {
                    "id": "T463",
                    "name": "Riboflavin",
                    "relevance": "LOW"
                },
                {
                    "id": "T470",
                    "name": "Vitamin B2",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Micro",
                    "name": "Micronutrients"
                },
                {
                    "abbrev": "Derm",
                    "name": "Dermatologic Agents"
                },
                {
                    "abbrev": "Vi",
                    "name": "Vitamins"
                }
            ]
        }
    },
    "hasResults": false
}